Supercoiling Structure-Based Design of a Trimeric Coiled-Coil Peptide with High Potency against HIV-1 and Human β-Coronavirus Infection
Chao Wang, Shibo Jiang(Shanghai Medical College of Fudan University), Ruiying Liang(Friedrich-Alexander-Universität Erlangen-Nürnberg), Qinwen Jiang(Shenyang Pharmaceutical University), Qiaoshuai Lan(Chinese University of Hong Kong), Huan Wang, Lu Lu(Shanghai Medical College of Fudan University), Yue Li, Qian Wang(Shanghai Medical College of Fudan University), Qing Li(Army Medical University), Shuai Xia(Shanghai Public Health Clinical Center), Fei Yu(New York Blood Center), Rong Xiang(Hebei Agricultural University), Keliang Liu, Xinling Wang(Shanghai Public Health Clinical Center), Shanshan Huo(Hebei Agricultural University)
Cited by 17
Related Papers
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
|Cellular and Molecular Immunology|2020|759
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
|RePEc: Research Papers in Economics|0|647
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
|Nature Communications|2014|400
The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin
|Signal Transduction and Targeted Therapy|2020|363